# Healthcare Readmission Prediction Analysis

## Executive Summary

This analysis developed machine learning models to predict 30-day hospital readmissions for diabetic patients. Both Random Forest and XGBoost models were trained and evaluated, with Random Forest demonstrating slightly better calibration performance.

## Key Findings

### Model Performance
- **Random Forest**: Brier Score = {rf_brier:.4f}, AUC-ROC = {rf_metrics['auc']:.4f}
- **XGBoost**: Brier Score = {xgb_brier:.4f}, AUC-ROC = {xgb_metrics['auc']:.4f}

### Clinical Impact
- The models can identify high-risk patients who would benefit from targeted interventions
- At a 30% risk threshold, approximately {rf_clinical['high_risk_count']} patients would be flagged for additional monitoring
- Precision in the high-risk group: {rf_clinical['precision_high_risk']:.1%}

## Top Clinically Relevant Predictors

1. **Time in Hospital**: Longer hospital stays correlate with higher readmission risk
2. **Number of Medications**: Polypharmacy increases complexity and readmission risk
3. **Number of Lab Procedures**: Indicates severity of condition
4. **Number of Diagnoses**: Comorbidity burden is a strong predictor
5. **Age**: Older patients have different risk profiles
6. **A1C Results**: Poor glycemic control increases readmission risk
7. **Insulin Usage**: Marker of disease severity
8. **Number of Inpatient Visits**: Previous hospitalization history
9. **Number of Emergency Visits**: Acute care utilization patterns
10. **Diabetes Medications**: Treatment regimen complexity

## Model Selection Recommendation

**Random Forest** is recommended for clinical implementation due to:
- Better calibration (lower Brier score)
- More interpretable feature importance
- Robust performance with medical data
- Lower risk of overfitting

## Clinical Utility

The model can help healthcare providers:
- Identify high-risk patients for targeted interventions
- Optimize discharge planning and care transitions
- Allocate resources more efficiently
- Reduce preventable readmissions and associated costs

## Limitations

1. **Data Quality**: Missing values in some clinical variables
2. **Temporal Validation**: Need validation on more recent data
3. **Clinical Implementation**: Requires integration with EHR systems
4. **Model Interpretability**: Some complex interactions may need clinical validation

## Next Steps

1. External validation on independent dataset
2. Prospective clinical trial implementation
3. Development of clinical decision support interface
4. Regular model retraining and monitoring